Testing for Alzheimer Disease in Asymptomatic Adults

This Viewpoint discusses the uncertain prognostic value of testing for Alzheimer disease biomarkers in asymptomatic individuals and warns of the possible insurance, employment, financial, and psychological repercussions of positive results of such tests.

Corresponding Author: Gayatri Devi, MD, MS, Park Avenue Neurology, 65 E 76th St, Ste 1A, New York, NY 10021 (gd@nybrain.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.